IRIS Accounts Production v25.2.0.378 12311210 director 1.12.23 30.11.24 30.11.24 false true false false false true false Ordinary A 0.01000 Ordinary B 0.01000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh123112102023-11-30123112102024-11-30123112102023-12-012024-11-30123112102022-11-30123112102022-12-012023-11-30123112102023-11-3012311210ns15:EnglandWales2023-12-012024-11-3012311210ns14:PoundSterling2023-12-012024-11-3012311210ns10:Director12023-12-012024-11-3012311210ns10:PrivateLimitedCompanyLtd2023-12-012024-11-3012311210ns10:SmallEntities2023-12-012024-11-3012311210ns10:AuditExempt-NoAccountantsReport2023-12-012024-11-3012311210ns10:SmallCompaniesRegimeForDirectorsReport2023-12-012024-11-3012311210ns10:SmallCompaniesRegimeForAccounts2023-12-012024-11-3012311210ns10:FullAccounts2023-12-012024-11-301231121012023-12-012024-11-3012311210ns10:OrdinaryShareClass12023-12-012024-11-3012311210ns10:OrdinaryShareClass22023-12-012024-11-3012311210ns10:RegisteredOffice2023-12-012024-11-3012311210ns5:CurrentFinancialInstruments2024-11-3012311210ns5:CurrentFinancialInstruments2023-11-3012311210ns5:ShareCapital2024-11-3012311210ns5:ShareCapital2023-11-3012311210ns5:RetainedEarningsAccumulatedLosses2024-11-3012311210ns5:RetainedEarningsAccumulatedLosses2023-11-3012311210ns5:NetGoodwill2023-12-012024-11-3012311210ns5:IntangibleAssetsOtherThanGoodwill2023-12-012024-11-3012311210ns5:PlantMachinery2023-12-012024-11-3012311210ns5:ComputerEquipment2023-12-012024-11-3012311210ns5:NetGoodwill2023-11-3012311210ns5:NetGoodwill2024-11-3012311210ns5:NetGoodwill2023-11-3012311210ns5:PlantMachinery2023-11-3012311210ns5:ComputerEquipment2023-11-3012311210ns5:PlantMachinery2024-11-3012311210ns5:ComputerEquipment2024-11-3012311210ns5:PlantMachinery2023-11-3012311210ns5:ComputerEquipment2023-11-3012311210ns5:CostValuation2023-11-3012311210ns5:AdditionsToInvestments2024-11-3012311210ns5:CostValuation2024-11-3012311210ns5:WithinOneYearns5:CurrentFinancialInstruments2024-11-3012311210ns5:WithinOneYearns5:CurrentFinancialInstruments2023-11-3012311210ns10:OrdinaryShareClass12024-11-3012311210ns10:OrdinaryShareClass22024-11-3012311210ns5:RetainedEarningsAccumulatedLosses2023-11-3012311210ns5:RetainedEarningsAccumulatedLosses2023-12-012024-11-30123112101ns10:Director12023-11-30123112101ns10:Director12022-11-30123112101ns10:Director12023-12-012024-11-30123112101ns10:Director12022-12-012023-11-30123112101ns10:Director12024-11-30123112101ns10:Director12023-11-30
REGISTERED NUMBER: 12311210 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 November 2024

for

South Coast Vascular Limited

South Coast Vascular Limited (Registered number: 12311210)






Contents of the Financial Statements
for the Year Ended 30 November 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


South Coast Vascular Limited

Company Information
for the Year Ended 30 November 2024







DIRECTOR: Mr L D Wijesinghe





REGISTERED OFFICE: Solent House
107a Alma Road
Southampton
SO14 6UY





REGISTERED NUMBER: 12311210 (England and Wales)





ACCOUNTANTS: Thomas Croft Limited
Accountants And Taxation Consultants
Solent House
107a Alma Road
Portswood
Southampton
Hampshire
SO14 6UY

South Coast Vascular Limited (Registered number: 12311210)

Balance Sheet
30 November 2024

30.11.24 30.11.23
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - 10,000
Tangible assets 5 1,641 2,440
Investments 6 105,692 89,151
107,333 101,591

CURRENT ASSETS
Debtors 7 13,383 16,276
Cash at bank 76,282 75,472
89,665 91,748
CREDITORS
Amounts falling due within one year 8 6,420 16,051
NET CURRENT ASSETS 83,245 75,697
TOTAL ASSETS LESS CURRENT
LIABILITIES

190,578

177,288

CAPITAL AND RESERVES
Called up share capital 9 1 1
Retained earnings 10 190,577 177,287
SHAREHOLDERS' FUNDS 190,578 177,288

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

South Coast Vascular Limited (Registered number: 12311210)

Balance Sheet - continued
30 November 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 12 August 2025 and were signed by:





Mr L D Wijesinghe - Director


South Coast Vascular Limited (Registered number: 12311210)

Notes to the Financial Statements
for the Year Ended 30 November 2024

1. STATUTORY INFORMATION

South Coast Vascular Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2019, is being amortised evenly over its estimated useful life of five years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% on reducing balance
Computer equipment - 33% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

South Coast Vascular Limited (Registered number: 12311210)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2024

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 December 2023
and 30 November 2024 50,000
AMORTISATION
At 1 December 2023 40,000
Amortisation for year 10,000
At 30 November 2024 50,000
NET BOOK VALUE
At 30 November 2024 -
At 30 November 2023 10,000

5. TANGIBLE FIXED ASSETS
Plant and Computer
machinery equipment Totals
£    £    £   
COST
At 1 December 2023
and 30 November 2024 110 2,361 2,471
DEPRECIATION
At 1 December 2023 31 - 31
Charge for year 20 779 799
At 30 November 2024 51 779 830
NET BOOK VALUE
At 30 November 2024 59 1,582 1,641
At 30 November 2023 79 2,361 2,440

South Coast Vascular Limited (Registered number: 12311210)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2024

6. FIXED ASSET INVESTMENTS
Other
investments
£   
COST OR VALUATION
At 1 December 2023 89,151
Additions 16,541
At 30 November 2024 105,692
NET BOOK VALUE
At 30 November 2024 105,692
At 30 November 2023 89,151

Cost or valuation at 30 November 2024 is represented by:

Other
investments
£   
Valuation in 2024 105,692

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.11.24 30.11.23
£    £   
Trade debtors 3,555 9,551
Prepayments 9,828 6,725
13,383 16,276

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.11.24 30.11.23
£    £   
Corporation tax 3,928 10,237
Other creditors 500 1,000
Directors' current accounts 552 3,553
Accrued expenses 1,440 1,261
6,420 16,051

South Coast Vascular Limited (Registered number: 12311210)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2024

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.11.24 30.11.23
value: £    £   
60 Ordinary A £0.01 1 1
40 Ordinary B £0.01 - -
1 1

10. RESERVES
Retained
earnings
£   

At 1 December 2023 177,287
Profit for the year 14,290
Dividends (1,000 )
At 30 November 2024 190,577

11. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 30 November 2024 and 30 November 2023:

30.11.24 30.11.23
£    £   
Mr L D Wijesinghe
Balance outstanding at start of year (3,552 ) (60,894 )
Amounts advanced 4,685 59,557
Amounts repaid (1,685 ) (2,215 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (552 ) (3,552 )